[HTML][HTML] Diagnostic testing for interstitial lung disease in common variable immunodeficiency: a systematic review

HM Bintalib, A van de Ven, J Jacob… - Frontiers in …, 2023 - frontiersin.org
Introduction Common variable immunodeficiency related interstitial lung disease (CVID-ILD,
also referred to as GLILD) is generally considered a manifestation of systemic immune …

2‐Deoxy‐D‐Glucose: A Novel Pharmacological Agent for Killing Hypoxic Tumor Cells, Oxygen Dependence‐Lowering in Covid‐19, and Other Pharmacological …

R Singh, V Gupta, A Kumar… - … in Pharmacological and …, 2023 - Wiley Online Library
The nonmetabolizable glucose analog 2‐deoxy‐D‐glucose (2‐DG) has shown promising
pharmacological activities, including inhibition of cancerous cell growth and N …

[HTML][HTML] Raised serum markers of T cell activation and exhaustion in granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency

MSA Fraz, AE Michelsen, N Moe, TM Aaløkken… - Journal of clinical …, 2022 - Springer
Abstract Purpose About 20–30% of patients with common variable immunodeficiency (CVID)
develop granulomatous-lymphocytic interstitial lung disease (GLILD) as one of several non …

The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease

B Smits, S Goldacker, S Seneviratne… - Journal of Allergy and …, 2023 - Elsevier
Background Granulomatous and lymphocytic interstitial lung disease (gl-ILD) is a major
cause of morbidity and mortality among patients with common variable immunodeficiency …

[HTML][HTML] Radiological Characteristics of Patients With Anti-MDA5–Antibody-Positive Dermatomyositis in 18F-FDG PET/CT: A Pilot Study

H Cao, J Liang, D Xu, Y Liu, Y Yao, Y Sun, Y He… - Frontiers in …, 2021 - frontiersin.org
Objective: To elucidate the 18F-fluorodeoxyglucose (FDG) PET/CT characteristics and its
prognostic value in the patients with anti-melanoma differentiation associated protein 5 …

[HTML][HTML] Integrating clinics, laboratory, and imaging for the diagnosis of common variable immunodeficiency-related granulomatous–lymphocytic interstitial lung …

MD Cabanero-Navalon, V Garcia-Bustos… - Frontiers in …, 2022 - frontiersin.org
Background Granulomatous–lymphocytic interstitial lung disease (GLILD) is a distinct clinic-
radio-pathological interstitial lung disease (ILD) that develops in 9% to 30% of patients with …

Bronchial inflammation biomarker patterns link humoral immunodeficiency with bronchiectasis‐related small airway dysfunction

UM Zissler, A Thron, J Eckrich… - Clinical & …, 2022 - Wiley Online Library
Background The progression of chronic destructive lung disease in patients with humoral
immunodeficiency (ID) and concomitant development of bronchiectasis is difficult to prevent …

[HTML][HTML] The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19

MT Griffin, TJ Werner, A Alavi, ME Revheim - The European Physical …, 2023 - Springer
Abstract The pathogenesis of Coronavirus Disease 2019 (COVID-19) involves cytokine-
driven recruitment and accumulation of inflammatory cells at sites of infection. These …

[HTML][HTML] Common and Uncommon CT Findings in CVID-Related GL-ILD: Correlations with Clinical Parameters, Therapeutic Decisions and Potential Implications in the …

R Scarpa, F Cinetto, C Milito, S Gianese… - Journal of Clinical …, 2023 - Springer
Purpose To investigate computed tomography (CT) findings of Granulomatous Lymphocytic
Interstitial Lung Disease (GL-ILD) in Common Variable Immunodeficiency (CVID), also in …

Granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency

HM Bintalib, SO Burns, JR Hurst - Rare Diseases of the …, 2023 - books.google.com
Granulomatous and lymphocytic ILD (GLILD) is a rare noninfectious complication affecting
patients with common variable immunodeficiency disorder (CVID). Although the …